Cargando…

A short purification process for quantitative isolation of PrP(Sc) from naturally occurring and experimental transmissible spongiform encephalopathies

BACKGROUND: Transmissible spongiform encephalopathies (TSEs) are neurodegenerative diseases affecting both humans and animals. They are associated with post-translational conversion of the normal cellular prion protein (PrP(C)) into a heat- and protease-resistant abnormal isoform (PrP(Sc)). Detectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Polymenidou, Magdalini, Verghese-Nikolakaki, Susan, Groschup, Martin, Chaplin, Melanie J, Stack, Mick J, Plaitakis, Andreas, Sklaviadis, Theodoros
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC134455/
https://www.ncbi.nlm.nih.gov/pubmed/12370086
http://dx.doi.org/10.1186/1471-2334-2-23
_version_ 1782120395733729280
author Polymenidou, Magdalini
Verghese-Nikolakaki, Susan
Groschup, Martin
Chaplin, Melanie J
Stack, Mick J
Plaitakis, Andreas
Sklaviadis, Theodoros
author_facet Polymenidou, Magdalini
Verghese-Nikolakaki, Susan
Groschup, Martin
Chaplin, Melanie J
Stack, Mick J
Plaitakis, Andreas
Sklaviadis, Theodoros
author_sort Polymenidou, Magdalini
collection PubMed
description BACKGROUND: Transmissible spongiform encephalopathies (TSEs) are neurodegenerative diseases affecting both humans and animals. They are associated with post-translational conversion of the normal cellular prion protein (PrP(C)) into a heat- and protease-resistant abnormal isoform (PrP(Sc)). Detection of PrP(Sc) in individuals is widely utilized for the diagnosis of prion diseases. METHODS: TSE brain tissue samples have been processed in order to quantitatively isolate PrP(Sc). The protocol includes an initial homogenization, digestion with proteinase K and salt precipitation. RESULTS: Here we show that over 97 percent of the PrP(Sc) present can be precipitated from infected brain material using this simple salting-out procedure for proteins. No chemically harsh conditions are used during the process in order to conserve the native quality of the isolated protein. CONCLUSION: The resulting PrP(Sc)-enriched preparation should provide a suitable substrate for analyzing the structure of the prion agent and for scavenging for other molecules with which it may associate. In comparison with most methods that exist today, the one described in this study is rapid, cost-effective and does not demand expensive laboratory equipment.
format Text
id pubmed-134455
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1344552002-11-20 A short purification process for quantitative isolation of PrP(Sc) from naturally occurring and experimental transmissible spongiform encephalopathies Polymenidou, Magdalini Verghese-Nikolakaki, Susan Groschup, Martin Chaplin, Melanie J Stack, Mick J Plaitakis, Andreas Sklaviadis, Theodoros BMC Infect Dis Research Article BACKGROUND: Transmissible spongiform encephalopathies (TSEs) are neurodegenerative diseases affecting both humans and animals. They are associated with post-translational conversion of the normal cellular prion protein (PrP(C)) into a heat- and protease-resistant abnormal isoform (PrP(Sc)). Detection of PrP(Sc) in individuals is widely utilized for the diagnosis of prion diseases. METHODS: TSE brain tissue samples have been processed in order to quantitatively isolate PrP(Sc). The protocol includes an initial homogenization, digestion with proteinase K and salt precipitation. RESULTS: Here we show that over 97 percent of the PrP(Sc) present can be precipitated from infected brain material using this simple salting-out procedure for proteins. No chemically harsh conditions are used during the process in order to conserve the native quality of the isolated protein. CONCLUSION: The resulting PrP(Sc)-enriched preparation should provide a suitable substrate for analyzing the structure of the prion agent and for scavenging for other molecules with which it may associate. In comparison with most methods that exist today, the one described in this study is rapid, cost-effective and does not demand expensive laboratory equipment. BioMed Central 2002-10-08 /pmc/articles/PMC134455/ /pubmed/12370086 http://dx.doi.org/10.1186/1471-2334-2-23 Text en Copyright © 2002 Polymenidou et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research Article
Polymenidou, Magdalini
Verghese-Nikolakaki, Susan
Groschup, Martin
Chaplin, Melanie J
Stack, Mick J
Plaitakis, Andreas
Sklaviadis, Theodoros
A short purification process for quantitative isolation of PrP(Sc) from naturally occurring and experimental transmissible spongiform encephalopathies
title A short purification process for quantitative isolation of PrP(Sc) from naturally occurring and experimental transmissible spongiform encephalopathies
title_full A short purification process for quantitative isolation of PrP(Sc) from naturally occurring and experimental transmissible spongiform encephalopathies
title_fullStr A short purification process for quantitative isolation of PrP(Sc) from naturally occurring and experimental transmissible spongiform encephalopathies
title_full_unstemmed A short purification process for quantitative isolation of PrP(Sc) from naturally occurring and experimental transmissible spongiform encephalopathies
title_short A short purification process for quantitative isolation of PrP(Sc) from naturally occurring and experimental transmissible spongiform encephalopathies
title_sort short purification process for quantitative isolation of prp(sc) from naturally occurring and experimental transmissible spongiform encephalopathies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC134455/
https://www.ncbi.nlm.nih.gov/pubmed/12370086
http://dx.doi.org/10.1186/1471-2334-2-23
work_keys_str_mv AT polymenidoumagdalini ashortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies
AT verghesenikolakakisusan ashortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies
AT groschupmartin ashortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies
AT chaplinmelaniej ashortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies
AT stackmickj ashortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies
AT plaitakisandreas ashortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies
AT sklaviadistheodoros ashortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies
AT polymenidoumagdalini shortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies
AT verghesenikolakakisusan shortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies
AT groschupmartin shortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies
AT chaplinmelaniej shortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies
AT stackmickj shortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies
AT plaitakisandreas shortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies
AT sklaviadistheodoros shortpurificationprocessforquantitativeisolationofprpscfromnaturallyoccurringandexperimentaltransmissiblespongiformencephalopathies